A- Preferred shares and subject to approval by Share Holders meeting on 5th April 2012, proposal amendment date 7th July 2012 exercise date 2015, Upon approval of Marqibo by FDA, This would adjust the investments made by WP for conducting clinical trials, etc etc...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.